Human Anti-VEGF Recombinant Antibody (clone B20-4)
Recombinant Human Antibody (B20-4) is capable of binding to VEGF, expressed in HEK293 cells. Expressed as the combination of a heavy chain (HC) containing VH from antiVEGF mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from antiVEGF mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.
Human Anti-VEGF Recombinant Antibody (clone B20-4)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Recombinant Human Antibody (B20-4) is capable of binding to VEGF, expressed in HEK293 cells. Expressed as the combination of a heavy chain (HC) containing VH from antiVEGF mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from antiVEGF mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition. This antibody binds and blocks both human and murine vascular endothelial growth factor (VEGF). It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Human Anti-VEGF Recombinant Antibody (clone B20-4)
- abbr: Anti-VEGF Antibody (clone B20-4)
- Target: VEGF
- Host Animal: Human
- Specificity: Human VEGF
- Immunogen: Human Vascular endothelial growth factor
Relevant Applications
- ELISA
- Neut
- Block
- This antibody has been reported for use in Enzyme-linked Immunosorbent Assay
- Neutralization
- Blocking.
